MTX intolerance in children and adolescents with juvenile idiopathic arthritis

Volume: 59, Issue: 7, Pages: 1482 - 1488
Published: Apr 7, 2020
Abstract
MTX is the medication most commonly used for antirheumatic treatment in juvenile idiopathic arthritis. It has high efficacy, is usually well tolerated and has an excellent safety profile. However, frequently intolerance symptoms develop that manifest as nausea, feelings of disgust or abdominal complaints prior to or directly after administration of the medication. No obvious toxicity is causing these intolerance symptoms, but symptoms are...
Paper Details
Title
MTX intolerance in children and adolescents with juvenile idiopathic arthritis
Published Date
Apr 7, 2020
Volume
59
Issue
7
Pages
1482 - 1488
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.